Form 8-K - Current report:
SEC Accession No. 0001104659-21-144174
Filing Date
2021-11-29
Accepted
2021-11-29 10:33:19
Documents
14
Period of Report
2021-11-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2134077d1_8k.htm   iXBRL 8-K 25952
2 EXHIBIT 99.1 tm2134077d1_ex99-1.htm EX-99.1 12361
6 GRAPHIC logo.jpg GRAPHIC 1961
  Complete submission text file 0001104659-21-144174.txt   218310

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA fencf-20211129.xsd EX-101.SCH 3025
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fencf-20211129_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fencf-20211129_pre.xml EX-101.PRE 22358
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2134077d1_8k_htm.xml XML 3634
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32295 | Film No.: 211453568
SIC: 2836 Biological Products, (No Diagnostic Substances)